Cancer drugs may be effective in treating chronic lung inflammation: Study
PTI, Jan 8, 2020, 11:46 AM IST
London: Cancer drugs may potentially work as an effective treatment for the chronic obstructive pulmonary disease (COPD) – a type of lung disease characterised by long-term breathing problems, and poor airflow, according to a study.
Researchers, including those from the University of Sheffield in the UK, assessed the effect of drugs used to treat different cancer types on lung damage in people living with COPD.
According to the study, published in the journal eLife, COPD slowly develops over many years, with patients often not being aware they have it until their 40s or 50s.
It said the disease makes breathing progressively more difficult for the patients, with symptoms including breathlessness, coughing, and frequent chest infections.
As part of the study, the scientists screened a library of cancer drugs and identified a number of compounds which accelerate the death of the immune cells called neutrophils and promote healing in the lungs.
The findings revealed that specific cancer drugs can inhibit a cell signalling process controlling the death-rate of the harmful neutrophils.
Editing the genes coding for the cell signalling, further decreased inflammation, the scientists reported.
“COPD is usually treated with steroids and airway muscle relaxants which ease symptoms, but there is currently no effective treatment clinically available to counteract the damage it does to the lungs,” Lynne Prince study co-author from the University of Sheffield.
“Our research now shows that inhibitors of these cell signalling processes, or ErbB kinases, could have therapeutic potential in neutrophilic inflammatory disease,” Prince added.
The scientists believe these drugs may clear the damaging cells from the lungs of people living with COPD, preventing any further damage, and therefore the progression of the disease.
They believe repurposing existing drugs, may be an efficient approach for this.
“We are in desperate need of a new treatment for COPD, millions of people all over the world live with the disease and it has a massive impact on their quality of life, especially as the disease progresses,” said study co-author Stephen Renshaw.
Since inflammation caused by the neutrophils is also central to the progression of other chronic inflammatory diseases such as rheumatoid arthritis, the researchers believe the findings may offer insights to more such conditions.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
World COPD Day: Know your lung function
As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all
World Diabetes Day 2024: Kasturba Hospital Manipal Hosts Zumba Session at Malpe Beach to Raise Diabetes Awareness
World Diabetes Day: An overview of types of diabetes
World Diabetes Day: One-fourth of people living with diabetes in 2022 are in India, Lancet study estimates
MUST WATCH
Latest Additions
Siddaramaiah says confident of winning all three bypolls in Karnataka
Hop on! IT Minister Priyank Kharge checks out Uber Shuttle at Bengaluru Tech Summit
Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’
Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial
AIMPLB to hold its annual general sessions in Bengaluru from November 23
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.